The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer's disease.
Ando K, Ndjim M, Turbant S, Fontaine G, Pregoni G, Dauphinot L, Yilmaz Z, Suain V, Mansour S, Authelet M, De Dekker R, Leroy K, Delatour B; Brain Bank NeuroCEB Neuropathology Network; Duyckaerts C, Potier MC, Brion JP.
Ando K, et al. Among authors: duyckaerts c.
Acta Neuropathol Commun. 2020 Jun 3;8(1):79. doi: 10.1186/s40478-020-00954-1.
Acta Neuropathol Commun. 2020.
PMID: 32493451
Free PMC article.